SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CVRX

CVRx, Inc. (NASDAQ:CVRX)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$0.50-$0.03 (-5.99%)
 
Market cap
$14.3M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 30, 2021
Market Cap$14.27M-94.9%
Revenue (ttm)$60.33M+7.8%
Net Income-$53.26M-2.4%
EPS-$2.01+0.5%
Shares Out28.48M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume519,859
Open$0.55
Previous Close$0.53
Day's Range$0.50 - $0.56
52-Week Range$0.50 - $10.28
Beta0.76
AnalystsBuy
Price Target$3.70(+638.52%)
Earnings DateFeb 11, 2027

About CVRX

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.

Address
9201 West Broadway Avenue, Minneapolis, MN, 55445, US
Market Cap
14 million
Employees
223
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$230.56K
Bought
$376.86K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Hold
0 Buy3 Hold0 SellAvg target $2.75 (+448.9%)

3 firms rating CVRX in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Weak
From CVRX’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-5.99%
5 Days
-19.19%
1 Month
-63.43%
6 Months
-91.75%
1 Year
-94.91%

$CVRX stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of CVRX by members of U.S. Congress

Richard BlumenthalSenate / DSale$1.00K – $15.00KJul 8, 2026

Recently reported changes in CVRX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CVRX's directors and management

Net Shares Purchased by Insiders−40k−20k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CVRX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CVRX Revenue by Segment or Geography

CVRX's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CVRX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CVRX from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CVRX

VTIVanguard Morningstar Total Stock Market ETF$705.07K
VXFVanguard Extended Market ETF$288.39K
IWMiShares Russell 2000 ETF$199.67K
VTWOVanguard Russell 2000 ETF$126.48K
IWOiShares Russell 2000 Growth ETF$84.30K
IWCiShares Micro-Cap ETF$24.97K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CVRX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
41.86
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
3
Sells
10
Buy Value
$376.86K
Distinct Buyers
2

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.02%

Weight is the stock’s share of each fund’s holdings.